Anavex Life Sciences Corp.

AVXL | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.44

+$0.04 (+1.67%)

Sep 22, 2026, 11:20 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Sep 29, 2025	FY 2024 Sep 29, 2024	FY 2023 Sep 29, 2023	FY 2022 Sep 29, 2022	FY 2021 Sep 29, 2021	FY 2020 Sep 29, 2020
Cash & Equivalents	102.58M	132.19M	151.02M	149.16M	152.11M	29.25M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	3.36M	3.55B	16.37K	5.29M
Receivables	809K	2.45M	2.71M	3.19M	9.14M	4.85M
Inventory	n/a	n/a	n/a	n/a	16.37K	n/a
Other Current Assets	429K	931K	653K	162	-16.37K	n/a
Total Current Assets	103.82M	135.57M	154.39M	152.7M	161.62M	34.54M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	3.36M	3.55B	16.37K	5.29M
Total Assets	103.82M	135.57M	154.39M	152.7M	161.62M	34.54M
Account Payables	4.25M	9.63M	4.32M	3.82M	4.74M	3.99M
Deferred Revenue	805K	842K	917K	443.83K	443.83K	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.56M	1.53M	1.36M	-47	n/a	n/a
Total Current Liabilities	8.95M	15.3M	12.53M	10.21M	10.8M	7.31M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	8.95M	15.3M	12.53M	10.21M	10.8M	7.31M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a
Book Value	94.87M	120.26M	141.85M	142.49M	150.82M	27.24M
Book Value Per Share	1.11	1.44	1.78	1.85	2.16	0.47
Common Stock	87K	85K	82K	77.94K	75.92K	62.05K
Retained Earnings	-382.45M	-336.07M	-293.07M	-245.56M	-197.59M	-159.68M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	94.87M	120.26M	141.85M	142.49M	150.82M	27.24M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a